Pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) may further impair bone quality, and when combined with T2DM-related metabolic abnormalities, may amplify skeletal fragility in affected individuals [18]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.